Atlas Trials

Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence

Clinical trial NCT00525291 · COMPLETED

Trial details

NCT number
NCT00525291
Sponsor
University of Giessen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Fecal Incontinence
Start date
2007-07-01
Primary completion
2008-12-01
Enrollment
158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.